The role of natural killer cells in the pathogenesis of sepsis: The ongoing enigma

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Bohannon, Julia ^a   Guo, Yin ^a   Sherwood, Edward R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR;

APOPTOSIS; CELL COUNT; CELL FUNCTION; CYTOKINE PRODUCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; FEMALE; MALE; METABOLISM;

FEMALE; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 84870812398     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11881     Document Type: Note

References (11)

1. Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M, Study Group C Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis. Crit Care 2012, 16:R206. 10.1186/cc11838, 23098236, Study Group C.
2. Oberholzer A, Harter L, Feilner A, Steckholzer U, Trentz O, Ertel W. Differential effect of caspase inhibition on proinflammatory cytokine release in septic patients. Shock 2000, 14:253-257. discussion 7-8, 10.1097/00024382-200014030-00002, 11028539.
3. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487. 10.1016/j.it.2009.07.009, 19781994.
4. Muenzer JT, Davis CG, Chang K, Schmidt RE, Dunne WM, Coopersmith CM, Hotchkiss RS. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 2010, 78:1582-1592. 10.1128/IAI.01213-09, 2849407, 20100863.
5. Flohe SB, Agrawal H, Flohe S, Rani M, Bangen JM, Schade FU. Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis. Mol Med 2008, 14:247-256. 2249752, 18297128.
6. Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, Green JM. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 2012, 16:R112. 10.1186/cc11404, 22742734.
7. Etogo AO, Nunez J, Lin CY, Toliver-Kinsky TE, Sherwood ER. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J Immunol 2008, 180:6334-6345. 3413484, 18424757.
8. Herzig DS, Driver BR, Fang G, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med 2012, 185:291-300. 10.1164/rccm.201108-1560OC, 22135342.
9. McDunn JE, Hotchkiss RS. Leukocyte phenotyping to stratify septic shock patients. Crit Care 2009, 13:127. 10.1186/cc7748, 2689472, 19439023.
10. Marquardt N, Wilk E, Pokoyski C, Schmidt RE, Jacobs R. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol 2010, 40:1428-1439. 10.1002/eji.200940056, 20186880.
11. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM. Natural killer (NK) cells in antibacterial innate immunity: angels or devils?. Mol Med 2012, 18:270-285. 3324953, 22105606.